Vir Biotechnology, Inc. (VIR)
11.70
+0.58
(+5.22%)
USD |
NASDAQ |
Oct 09, 16:00
11.70
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Gross Profit Margin (Quarterly) : 98.83% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.83% |
| March 31, 2026 | |
| December 31, 2025 | 95.44% |
| September 30, 2025 | -1.14K% |
| June 30, 2025 | -141.2% |
| March 31, 2025 | 5.44% |
| December 31, 2024 | 71.15% |
| September 30, 2024 | -23.78% |
| June 30, 2024 | -40.23% |
| March 31, 2024 | 91.88% |
| December 31, 2023 | 68.56% |
| September 30, 2023 | -144.1% |
| June 30, 2023 | -84.30% |
| March 31, 2023 | 84.56% |
| December 31, 2022 | 83.91% |
| September 30, 2022 | 93.61% |
| Date | Value |
|---|---|
| June 30, 2022 | |
| March 31, 2022 | 92.39% |
| December 31, 2021 | 92.81% |
| September 30, 2021 | 89.56% |
| June 30, 2021 | 97.70% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -7.59% |
| Vaxcyte, Inc. | -- |
| Caribou Biosciences, Inc. | 58.31% |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
| Oncolytics Biotech, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.24% |
| Return on Assets | -22.97% |
| Return on Invested Capital | -26.25% |
| Profit Margin (Quarterly) | 33.51% |
| Operating Margin (Quarterly) | 31.22% |
| Return on Net Operating Assets | -176.5% |